Genscript Biotech Corporation (1548.HK)

HKD 9.95

(0.2%)

Net Debt Summary of Genscript Biotech Corporation

Genscript Biotech Corporation's latest annual net debt in 2023 was -1.02 Billion USD , down -52.69% from previous year.
Genscript Biotech Corporation's latest quarterly net debt in 2024 Q2 was 477.87 Million USD , up 157.31% from previous quarter.
Genscript Biotech Corporation reported annual net debt of -674.2 Million USD in 2022, up 34.19% from previous year.
Genscript Biotech Corporation reported annual net debt of -1.02 Billion USD in 2021, down -78.47% from previous year.
Genscript Biotech Corporation reported quarterly net debt of -1.02 Billion USD for 2023 FY, down -52.69% from previous quarter.
Genscript Biotech Corporation reported quarterly net debt of -1.02 Billion USD for 2023 Q4, down -1.28% from previous quarter.

Annual Net Debt Chart of Genscript Biotech Corporation (2023 - 2013)

Historical Annual Net Debt of Genscript Biotech Corporation (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	-1.02 Billion USD	-52.69%
2022	-674.2 Million USD	34.19%
2021	-1.02 Billion USD	-78.47%
2020	-574.05 Million USD	-151.49%
2019	-228.26 Million USD	52.84%
2018	-484.05 Million USD	-290.82%
2017	-123.85 Million USD	9.24%
2016	-136.46 Million USD	-31.57%
2015	-103.72 Million USD	-493.87%
2014	-17.46 Million USD	-15.92%
2013	-15.06 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	477.87 Million USD	157.31%
2023 FY	-1.02 Billion USD	-52.69%
2023 Q4	-1.02 Billion USD	-1.28%
2023 Q2	-1.01 Billion USD	-50.76%
2022 FY	-674.2 Million USD	34.19%
2022 Q4	-674.2 Million USD	-21.91%
2022 Q2	-553.01 Million USD	46.02%
2021 Q4	-1.02 Billion USD	-13.61%
2021 FY	-1.02 Billion USD	-78.47%
2021 Q2	-901.81 Million USD	-57.1%
2020 Q2	-648.18 Million USD	-183.96%
2020 Q4	-574.05 Million USD	11.44%
2020 FY	-574.05 Million USD	-151.49%
2019 FY	-228.26 Million USD	52.84%
2019 Q2	-258.89 Million USD	46.52%
2019 Q4	-228.26 Million USD	11.83%
2018 Q4	-484.05 Million USD	-7.09%
2018 FY	-484.05 Million USD	-290.82%
2018 Q2	-452 Million USD	-264.94%
2017 Q4	-123.85 Million USD	5.27%
2017 FY	-123.85 Million USD	9.24%
2017 Q2	-130.74 Million USD	4.19%
2016 FY	-136.46 Million USD	-31.57%
2016 Q4	-136.46 Million USD	-12.94%
2016 Q2	-120.83 Million USD	-16.5%
2015 FY	-103.72 Million USD	-493.87%
2015 Q2	-25.68 Million USD	-47.06%
2015 Q4	-103.72 Million USD	-303.83%
2014 FY	-17.46 Million USD	-15.92%
2014 Q4	-17.46 Million USD	0.0%
2013 FY	-15.06 Million USD	0.0%

Peer Net Debt Comparison of Genscript Biotech Corporation

Name	Net Debt	Net Debt Difference
Uni-Bio Science Group Limited	-76.36 Million HKD	-1247.946%
CK Life Sciences Int'l., (Holdings) Inc.	5.26 Billion HKD	119.545%